Grow clear, healthy nails. Without pain.
The world's first and only non-thermal laser with FDA 510(k) clearance and TGA registration for new clear nail growth in patients with onychomycosis.
How it works
Healthy nails. Simple protocol.
The Lunula Laser uses dual low-level laser beams to target fungal nail infection with no heat, no pain, and no recovery time — for practitioners and patients alike.
Turn on & walk away
Fully automated with a pre-set protocol. No manual aiming or staff monitoring required during the 12-minute session.
Treats all 5 toes at once
Computer-automated to ensure consistent coverage across all nails simultaneously — a feature unique to the Lunula platform.
No consumables
No ongoing supplies to manage or reorder. Low overhead, high patient throughput — a predictable revenue stream for your clinic.
Results in ~3 months
Visible improvements typically appear within 3 months, with average new clear nail growth of 6.1 mm measured at 6 months post-treatment.
The technology
Two wavelengths. One proven outcome.
Lunula uses two true laser beams — monochromatic, collimated, and coherent — to address both the infection and the body's repair process at the same time.
Kills the infection
The violet beam triggers a photochemical reaction that generates Reactive Oxygen Species, converted to hydrogen peroxide — a natural antiseptic that kills onychomycosis without heat or tissue damage.
Promotes healing
The red beam stimulates the body's natural healing mechanisms, accelerating clear nail regrowth and improving nail appearance — even in cases of non-fungal nail damage such as psoriasis or trauma.
Why Lunula
The Lunula advantage
A safer, more effective alternative to oral anti-fungals and thermal lasers — backed by Level 1 double-blind, randomised, placebo-controlled clinical trials.
100% pain-free, zero heatClassified as a cold laser — patients feel nothing. No risk of tissue burns unlike thermal laser alternatives.
No side effectsZero risk of liver toxicity, drug interactions, or microbial resistance — unlike oral terbinafine or ketoconazole.
First & only FDA-cleared LLLT deviceFor onychomycosis — the only non-thermal Low Level Laser Therapy with proven, regulatory-backed efficacy.
No dangerous smoke plumesSafe clinical environment for both practitioner and patient throughout treatment.
Short, unattended sessionsJust 12 minutes per session. Staff can attend to other patients while the device runs its automated protocol.
No ongoing consumablesLow running costs and predictable margins make it an easy addition to any podiatry or clinic revenue model.
Patient journey
What a course of treatment looks like
A straightforward, low-burden process that fits naturally into any podiatry workflow.
Assessment & suitability
Review the patient's history, photograph the affected nails for progress documentation, and confirm the laser is clinically appropriate. Many clinics also offer an optional in-house fungal confirmation test at this stage.
Debridement
Trim and debride the nails to minimise surface area. Aggressive debridement prior to treatment improves efficacy by allowing the laser beams to penetrate more efficiently.
12-minute Lunula session
The patient inserts their foot into the device. It runs automatically — no manual targeting, no heat, no discomfort. Treats all five toes simultaneously.
Repeat up to 4 sessions
Most patients complete four sessions spaced one week apart. Some cases may benefit from additional sessions at your clinical discretion.
Monitor & review
Track clear nail progress from photographs taken at each visit. Visible improvement typically appears within 3 months, with peak results at 6 months.
Technical specifications
Device specs
| Wavelengths | 405 nm (violet) + 635 nm (red) |
| Laser class | Class 2 — non-thermal cold laser |
| Session duration | 12 minutes (automated, pre-set protocol) |
| Minimum sessions | 4 sessions, spaced 1 week apart |
| Weight | 23 lbs (10.43 kg) |
| Accessories | 2 × keys, power cord, laser safety glasses |
| FDA clearance | FDA 510(k) · K153164 |
| TGA registration | ARTG 386651 |
| Certifications | ISO 13485 Medical Device Quality · ISO 14971 Risk Management · IEC 60825-1 Laser Safety · IEC 60601-1 MEE Safety · IEC 60601-1-2 EMC · CE Mark · CB Certificate |
| Origin | Made in the USA by Erchonia Corporation |
| Indications for use | Temporary increase of clear nail in patients with onychomycosis (dermatophytes incl. T. rubrum, T. mentagrophytes, and/or yeasts incl. C. albicans) |
| Consumables | None |
Trial options available
Speak with a RehaCare representative about adding the Lunula Laser to your clinic. We provide training, marketing materials, and ongoing support.
Supplied in Australia by RehaCare Pty Ltd · 7C/256 New Line Road, Dural NSW 2158 · 1300 653 522 · sales@rehacare.com.au